AAAAAA

   
Results: 1-8 |
Results: 8
HIV-associated hematologic disorders are correlated with plasma viral loadand improve under highly active antiretroviral therapy
Authors: Servais, J Nkoghe, T Schmit, JC Arendt, V Robert, I Staub, T Moutschen, M Schneider, F Hemmer, R
Citation: J. Servais et al., HIV-associated hematologic disorders are correlated with plasma viral loadand improve under highly active antiretroviral therapy, J ACQ IMM D, 28(3), 2001, pp. 221-225
Induced disease resistance in plants by chemicals
Authors: Oostendorp, M Kunz, W Dietrich, B Staub, T
Citation: M. Oostendorp et al., Induced disease resistance in plants by chemicals, EUR J PL P, 107(1), 2001, pp. 19-28
Indinavir hair concentration in highly active antiretroviral therapy-treated patients: association with viral load and drug resistance
Authors: Servais, J Peytavin, G Arendt, V Staub, T Schneider, F Hemmer, R Burtonboy, G Schmit, JC
Citation: J. Servais et al., Indinavir hair concentration in highly active antiretroviral therapy-treated patients: association with viral load and drug resistance, AIDS, 15(7), 2001, pp. 941-943
Characterizing resistance risk of Erysiphe graminis f.sp tritici to strobilurins
Authors: Chin, KM Chavaillaz, D Kaesbohrer, M Staub, T Felsenstein, FG
Citation: Km. Chin et al., Characterizing resistance risk of Erysiphe graminis f.sp tritici to strobilurins, CROP PROT, 20(2), 2001, pp. 87-96
Comparison of DNA sequencing and a line probe assay for detection of humanimmunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy
Authors: Servais, J Lambert, C Fontaine, E Plesseria, JM Robert, I Arendt, V Staub, T Schneider, F Hemmer, R Burtonboy, G Schmit, JC
Citation: J. Servais et al., Comparison of DNA sequencing and a line probe assay for detection of humanimmunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy, J CLIN MICR, 39(2), 2001, pp. 454-459
Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor
Authors: Servais, J Lambert, C Fontaine, E Plesseria, JM Robert, I Arendt, V Staub, T Schneider, F Hemmer, R Burtonboy, G Schmit, JC
Citation: J. Servais et al., Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor, ANTIM AG CH, 45(3), 2001, pp. 893-900
Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants
Authors: Mallet, E Fabre, P Pines, E Salomon, H Staub, T Schodel, F Mendelman, P Hessel, L Chryssomalis, G Vidor, E Hoffenbach, A
Citation: E. Mallet et al., Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants, PEDIAT INF, 19(12), 2000, pp. 1119-1127
Commercial development of elicitors of induced resistance to pathogens
Authors: Tally, A Oostendorp, M Lawton, K Staub, T Bassi, B
Citation: A. Tally et al., Commercial development of elicitors of induced resistance to pathogens, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, 1999, pp. 357-369
Risultati: 1-8 |